Abituzumab Terminated Phase 2 Trials for Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02745145 | Abituzumab in SSc-ILD |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02745145 | Abituzumab in SSc-ILD |